Telomerase in cancer: Diagnostic, prognostic, and therapeutic implications

Cancer Journal from Scientific American

Volumn 4, Issue SUPPL. 1, 1998, Pages

  Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; TELOMERASE;

ARTICLE; CANCER DIAGNOSIS; CELL AGING; EARLY DIAGNOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031816339     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (128)

1. Parker SL, Tong T, Bolden S et al. Cancer statistics. CA Cancer J Clin 1997;47:5-27.
2. Ries LAG, Kosary L, Hankey BF et al. SEER cancer statistics review, 1973-1993: tables and graphs. Bethesda, Maryland: Nation al Institutes of Health, 1997.
3. Hong KW, Sporn MB. Recent advances in chemoprevention. Science 1997;278:1073-1077.
4. Hartwell LH, Szankasi P, Roberts CJ et al. Integrating genetic approaches into the discovery of anticancer drugs. Science 1997; 278:1064-1068.
5. Srivastava S, Rossi SC. Early detection research program at the NCI. Int J Cancer 1996;69:35-37.
6. Breslow RA, Shay JW, Gazdar AF et al. Telomerase and early detection of cancer: a National Cancer Institute workshop. J Natl Cancer Inst 1997;89:618-623.
7. Shay JW, Gazdar AF. Telomerase in the early detection of cancer. J Clin Pathol 1997;50:106-109.
8. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science 1997;278:1054-1058.
9. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961;25:585-621.
10. Sager R. Senescence as a mode of tumor suppression. Environ Health Perspect 1991;93:59-62.
11. Campisi J. The biology of replicative senescence. Eur J Cancer 1997;33:703-709.
12. Newbold RF, Overell RW, Connell JR Induction of immortality is an early event in malignant transformation of mammalian cells by carcinogens. Nature 1982;299:633-635.
13. Shay JW. Molecular pathogenesis of aging and cancer: are telomeres and telomerase the connection? (editorial). J Clin Pathol 1997;50:799-800.
14. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991;256:271-282.
15. Shay JW, Wright WE, Werbin H. Defining the molecular mechanism of human cell immortalization. Biochim Biophys Acta 1991;1072:1-7.
16. Harley CB, Kim NW, Prowse KR et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 1994;59: 307-315.
17. Allsopp RC, Vaziri H, Patterson C. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114-10118.
18. Olovnikov AM. A theory of marginotomy. J Theor Biol 1973;41: 181-190.
19. Cooke HJ, Smith BA. Variability at the telomeres of the human X/Y pesudoautosomal region. Cold Spring Harb Symp Quant Biol 1986;50:213-219.
20. Allshire RC et al. Telomeric repeat from T. themophila cross hybridize the human telomeres. Nature 1988;332:656-659.
21. Lundblad V, Szostak JW. A mutant with defect in telomere elongation leads to senescence in yeast. Cell 1989;57:633-643.
22. Harley CB, Futcher BA, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990;345:458-460.
23. Greider CW. Telomeres, telomerase and senescence. Bioessays 1990;12:363-369.
24. Hastie ND, Dempster M, Dunlop MG et al. Telomere reduction in human colorectal carcinoma and with aging. Nature 1990; 346:866-868.
25. deLange T, Shiue L, Myers MR et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990;10:518-527.
26. Allsopp RC, Harley CB. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 1995;219:130-136.
27. Moyzis RK, Buckingham JM, Cram LS et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988;85:6622-6626.
28. Watson JD. Origin of concatemeric T7 DNA. Nat New Biol 1972;239:197-201.
29. Lindsey J, McGill NI, Lindsey LA, et al. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991;256:45-48.
30. Wright WE, Brasiskyte D, Piatyszek MA, et al. Experimental elongation of telomeres in immortal human cells extends the lifespan of immortal x normal cell hybrids. EMBO J 1996;15:1734-1741.
31. Bodnar AG, Ouellete M, Frolkis M et al. Extension of lifespan by introduction of telomerase in normal human cells. Science 1998; 279:349-352.
32. Blackburn EH. Structure and function of telomeres. Nature 1991; 350:569-573.
33. Zakian VA. Structure and function of telomeres. Annu Rev Genet 1989;23:579-604.
34. Kirk KE, Harmon BP, Reichardt IK et al. Block in anaphase chromosome separation caused by a telomerase template mutation. Science 1997;275:1478-1481.
35. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43:405-413.
36. Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 1989;337:331-337.
37. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59:521-529.
38. Wright WE, Piatyszek MA, Rainey WE et al. Telomerase activity in humn germline and embryonic tissues and cells. Dev Genet 1996;18:173-179.
39. Mantell L, Greider CW. Telomerase activity in germline and embryonic cells of Xenopus. Embo J 1994;13:3211-3217.
40. Hiyama E, Hiyama K, Tatsumoto N, et al. Telomerase activity in human intestine. Int J Oncol 1996;9:1-6.
41. Taylor RS, Ramirez RD, Ogoshi M, et al. Telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996;106:759-765.
42. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996;93:6476-6481.
43. Ramirez RD, Wright WE, Shay JW et al. Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 1997;108:113-117.
44. Counter CM, Gupta J, Harley CB et al. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85:2315-2320.
45. Broccoli D, Young JW, deLange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92:9082-9086.
46. Hiyama K, Hirai Y, Kyoizumi S et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995;155:3711-3715.
47. Chiu C-P, Dragowska W, Kim NW et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells (Dayt) 1996;14:239-248.
48. Norrback KF, Dahlenborg K, Carlsson R et al. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphoma. Blood 1996;88:222-229.
49. Weng NP, Levin BL, June CH et al. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996;183:2471-2479.
50. Buchovich KJ, Greider CW. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 1996;7: 1443-1445.
51. Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Commun 1996;219:649-655.
52. Bodner A, Kim NW, Effros RB et al. Mechanism of telomerase induction during T cell activation. Exp Cell Res 1996;228:58-64.
53. Iwama H, Ohyashiki K, Ohyashik J et al. Telomere length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum Genet 1998; in press.
54. Kyo S, Takakura M, Kohama T et al. Telomerase activity in human endometrium. Cancer Res 1997;57:610-614.
55. Saito T, Schneider A, Mattel N et al. Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis. Biochem Biphys Res Commun 231:610-614.
56. Brien TP, Kallakury BV, Lowry CV et al. Telomerase activity in benign endometrium and endometrial carcinomas. Cancer Res 1997;57:2760-2764.
57. Feng J, Funk WD, Wang S-S et al. The RNA component of human telomerase. Science 1995;269:1236-1241.
58. Lingner J, Hughes TR, Shevchenko A et al. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 1997;276: 561-567.
59. Nakamura TM, Morin GB, Chapman KT et al. Telomerase catalytic subunit homologs from fission yeast and humans. Science 1997;277:955-959.
60. Meyerson M, Counter CM, Eaton EN et al. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 1997;90:785-795.
61. Harrington L, Zhou W, McPhail T et al. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 1997;23:3109-3115.
62. Killian A, Bowtell DDL, Abudi HE et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997;12: 2011-2019.
63. Weinrich SL, Pruzan R, Ma L et al. Reconstitution of human telomerase with the catalytic protein subunit hTRT. Nat Genet 1997;17:498-502.
64. Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science 1997;278:1043-1050.
65. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2014.
66. Counter CM, Hirte HW, Bacchetti S et al. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994;91: 2900-2904.
67. Nilsson P, Mehle C, Remes R et al. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994;9:3043-3048.
68. Bacchetti S, Counter CM. Telomeres and telomerase in human cancer. Int J Oncol 1995;7:423-432.
69. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996;8:66-71.
70. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Can 1997;33:787-791.
71. Shay JW. Telomerase in human development and cancer. J Cell Physiol 1997;173:266-270.
72. Ohmura H, Tahara H, Suzuki M et al. Restoration of the cellular senescence program and repression of telomerase by chromosome 3. Jpn J Cancer Res 1995;86:899-904.
73. Yancik R. Integration of aging and cancer research in geriatric medicine. J Gerontol 1997;52:329-332.
74. Cohen HJ. Biology of aging as related to cancer. Cancer 1994;74: 2092-2100.
75. Shay JW, Brasiskyte D, Ouellete M et al. Methods for analysis of telomerase and telomeres. Methods Mol Genet 1994;5:263-280.
76. Holt SE, Norton JC, Wright WE et al. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze™ telomerase detection kit. Meth Cell Sci 1996;18:237-248.
77. Wright WE, Shay JW, Peatyszek MA. Modification of a telomeric repeat amplification protocol (TRAP) results in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995;23:3794-3795.
78. Norton JC, Gollahon LS, Holt SE et al. Enhanced detection of telomerase activity in tumor derived human cell lines. DNA Cell Biol 1998; in press.
79. Ohyashiki K, Ohyashiki J, Nishimaki J et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 1997;57:2100-2103.
80. Yahata N, Ohyashiki K, Ohyashiki J et al. Telomerase activity is detected in lung cancer cells obtained from bronchial washings. J Natl Cancer Inst 1998; in press.
81. Yashima K, Piatyszek MA, Saboorian HM et al. Expression of telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997;50: 110-117.
82. Yashima K, Litzky LA, Kaiser L et al. Telomerase expression in bronchial epithelium during multistage pathogenesis of lung carcinomas. Cancer Res 1997;57:2373-2377.
83. Yashima K, Milchgrub S, Gollahon L et al. Telomerase expression during multistage pathogenesis of breast carcinoma. Clin Cancer Res 1998;4:229-234.
84. Yashima K, Maitra A, Timmons CF et al. Expression of the RNA component of telomerase in Wilm's tumor and its precursor lesion recapitulates renal embryogenesis. Hum Pathol 1998; in press.
85. Rushing EJ, Yashima K, Brown DF et al. Expression of telomerase RNA component correlates with the MIB-1 index in ependymomas. J Neuropathol-Exp Neurol 1997;56:1142-1146.
86. Brown DF, Gazdar AF, Dababo MA et al. Human telomerase RNA expression and MIB-1 (Ki-67) proliferation index distinguish hemangioblastomas from metastatic renal cell carcinoma. J Neuropathol Exp Neurol 1998;56:1349-1355.
87. Soder AI, Hoare SF, Muir W et al. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 1997;14:1013-1021.
88. Clark GM, Osborne CK, Levitt D et al. Telomerase activity and survival of patients with node positive breast cancer. J Natl Cancer Inst 1997;89:1874-1880.
89. Haugen BR, Nawaz S, Markham N et al. Telomerase activity in benign and malignant thyroid tumors. Thyroid 1997;7:337-342.
90. Umbricht CB, Saji M, Westra WH et al. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res 1997;57:2144-2147.
91. Suehara N, Mizumoto K, Tanaka M et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res 1997;3:2479-2483.
92. Hiyama E, Kodama T, Shinbara K et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 1997;57:326-331.
93. Iwao T, Hiyama E, Yokoyama T et al. Telomerase activity for the preoperative diagnosis of pancreatic cancer. J Natl Cancer Inst 1997;89:1621-1623.
94. Scates DK, Muir GH, Venitt S et al. Detection of telomerase activity in human prostate: a diagnostic marker for prostate cancer. Br J Urol 1997;80:263-268.
95. Sommerfeld HJ, Meeker AK, Piatyszek MA et al. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1995;56:218-222.
96. Engelhardt M, Drullinsk P, Guillem J et al. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 1997;3:1931-1941.
97. Yoshida K, Sugino T, Goodison S et al. Detection of telomerase activity in exfoliated cancer cells in colonie luminal washings and its related clinical implications. Br J Cancer 1997;75:548-553.
98. Chadeneau C, Hay K, Hirte HW et al. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-2536.
99. Tahara H, Nakanishi T, Kitamoto M et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995;55:2734-2736.
100. Dalbagni G, Han W, Zhang Z-F et al. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 1997;3:1593-1598.
101. Kinoshita H, Ogawa O, Kakehi Y et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. J Natl Cancer Inst 1997;89:724-730.
102. Yoshida K, Sugino T, Tahara H et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997;79:362-369.
103. Lin Y, Miyamoto H, Fujinami K et al. Telomerase activity in human bladder cancer. Clin Cancer Res 1996;2:929-932.
104. Muller M, Heine B, Heivappell R et al. Telomerase activity in bladder cancer, bladder washings and in urine. Int J Oncol 1996; 19:1169-1173.
105. Kyo St, Takakura M, Ishikawa H. Application of telomerase assay for the screening of cervical lesion. Cancer Res 1997;57:1863-1867.
106. Langford LA, Piatyszek MA, Xu R et al. Telomerase activity: a prognostic indicator in ordinary meningiomas. Hum Pathol 1997;28:416-420.
107. Hiyama E, Hiyama K, Yokoyama T et al. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:249-255.
108. Ohyashiki JH, Ohyashiki K, Iwama H. Clinical implications of telomerase activity levels in acute leukemia. Clin Cancer Res 1997;3:619-625.
109. Zhang W, Piatyszek MA, Kobayashi T et al. Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 1996; 2:799-8031.
110. Hiyama E, Gollahon L, Kataoka T et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996;88:116-122.
111. Hiyama E, Yokoyama T, Tatsumoto N et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-3262.
112. Tahara H, Kuniyasu H, Yasui W et al. Telomerase activity in gastric and colorectal carcinomas correlates well with malignant progression. Clin Cancer Res 1995;1245-1251.
113. Faraoni I, Turriziana M, Masci G et al. Decline in telomerase activity as a mesure of tumor cell killing by antineoplastic agents in vitro. Clin Cancer Res 1997;3:579-585.
114. Morin GB. Is telomerase a universal cancer target? J Natl Cancer Inst 1995;87:859-861.
115. Shay JW. Aging and cancer: Are telomeres and telomerase the connection? Mol Med Today 1995;1:378-384.
116. Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 1995;5:249-255.
117. Harley CB. Telomeres and aging: fact, fancy, and the future. J NIH Res 1995;7:64-68.
118. deLange T. Activation of telomerase in a human tumor. Proc Natl Acad Sci USA 1994;91:2882-2885.
119. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-894.
120. Shay JW, Wright WE. The reactivation of telomerase activity in cancer progression. Trends Genet 1996;12:129-131.
121. Greider C. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 1998;95:90-92.
122. Norton JC, Piatyszek MA, Wright WE et al. Inhibition of human telomerase activity by peptide nucleic acid oligomers. Nat Biotechnol 1996;14:615-619.
123. Hamilton SE, Pitts A, Katipally R et al. Identification of determinants for inhibitor binding within the RNA active site of human telomerase using PNA scanning. Biochemistry 1997;36:11873-11880.
124. Strahl C, Blackburn EH. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two-immortalized human cell lines. Mol Cell Biol 1996;16:53-65.
125. Kanazawa Y, Ohkawa K, Ueda K et al. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Biochem Biophys Res Comm 1996;225:570-576.
126. Marusic L et al. Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability. Mol Cell Biol 1997;17:6394-6401.
127. Harrington L, McPhail T, Mar V et al. A mammalian telomerase-associated protein. Science 1997;275:973-977.
128. Chong L, Vansteensel B, Broccoli D et al. A human telomeric protein. Science 1997;270:1663-1667.